Remove Doctors Remove Life Sciences Remove Pharmaceuticals Remove Regulations
article thumbnail

The Gains and Pains of Using AI in the Pharmaceutical Industry

HIT Consultant

The proportion of pharmaceutical companies hiring for AI-related positions kept relatively steady in May 2022 compared with the equivalent month last year, according to a Pharmaceutical Technology study, with 39.3% of the companies included in the analysis recruiting for at least one such position. . Operational Challenges of AI.

article thumbnail

Pharma & Influencer Marketing: Can They Coexist Ethically?

HIT Consultant

Mike Szczesny, Owner & VP of EDCO Awards & Specialties Influencer marketing in the pharmaceutical industry is a complex issue with reasonable arguments on multiple sides. According to the FDA’s website , here are some regulations: Ads must be truthful.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Implementing Responsible AI to Drive Innovation in Clinical Research & Precision Medicine

HIT Consultant

These and other questions are compelling us, as AI practitioners, to think differently in terms of how we can best advance clinical research and precision medicine using responsible AI that benefits patients, providers, payers, pharmaceutical companies and medical care professionals while avoiding unintended consequences, including bias.

article thumbnail

Ozempic: From Diabetes Management to Potential Weight Loss Miracle

HIT Consultant

While pharmaceutical companies are bound by rigorous standards and regulations, independent influencers are not held to the same criteria. With a background in supporting doctors in the operating room, George saw the need for more significant support, education, and compassion for patients facing stressful medical experiences.

Doctors 98
article thumbnail

Healthcare Is Changing, Right? Here’s 5 Reasons It’s Not.

HIT Consultant

Kayt Leonard, Global Health Care and Life Sciences Strategic Advisor at SAS We hear it every day, right? Rising cost pressures from insurance companies, regulations aimed at reducing costs , and a generally complex and fragmented payment system can limit innovations that could improve patient outcomes. questionable.

article thumbnail

The Future of Digital Transformation in Hospitals

HIT Consultant

This includes both structured data (such as lab results and medications) and unstructured data (such as notes from doctors and nurses). HIPAA, GDPR regulations), data privacy risks (ie, that extend beyond the regulations), reputational risks (e.g., He is a former core member of BCG’s healthcare practice and hospital executive.

article thumbnail

Most Americans Across Party ID Favor U.S. Government Negotiation to Lower Rx Drug Costs

Health Populi

It’s no surprise, then, that one-half of Americans have spoken with their doctor about whether there is a less expensive alternative to a drug the physician has prescribed. That would be profits made by pharmaceutical companies, cited by 80% of respondents. The biggest culprit/contributor to prescription drug prices?